Ayala Pharmaceuticals Inc (ADXS)

[James salmon]

Dollar,

I also hold INO as well, which has done very well over the last few months. If you look at the sort of news they have put out recently re animal trials and impact on share price this has had, you have to wonder why market cap of INO is around 200 million and Adxs is only 19 million with human trial results they have put out.

INO is very much in favor at the moment, ADXS is not, it really does make a difference.

INO though is a good company with a lot of promise.